第一单位:
The Institute of Cancer Research, London, UK.
作者:
Juan M,Jiménez-Vacas [1]
;
Daniel,Westaby [2]
;
Ines,Figueiredo [1]
;
Alexis,De Haven Brandon [1]
;
Ana,Padilha [1]
;
Wei,Yuan [1]
;
George,Seed [1]
;
Denisa,Bogdan [1]
;
Bora,Gurel [1]
;
Claudia,Bertan [1]
;
Susana,Miranda [1]
;
Maryou,Lambros [1]
;
Antonio J,Montero-Hidalgo [3]
;
Ilsa,Coleman [4]
;
Ivan Pak Lok,Yu [5]
;
Lorenzo,Buroni [1]
;
Wanting,Zeng [1]
;
Antje J,Neeb [1]
;
Jon,Welti [1]
;
Jan,Rekowski [1]
;
Roberta,Paravati [1]
;
Florian,Gabel [1]
;
Nicole,Pandell [1]
;
Ana,Ferreira [1]
;
Mateus,Crespo [1]
;
Ruth,Riisnaes [1]
;
Souvik,Das [1]
;
Joe,Taylor [1]
;
Nick,Waldron [1]
;
Emily,Hobern [1]
;
Melanie,Valenti [1]
;
Jian,Ning [1]
;
Ilona,Bernett [1]
;
Kate,Liodaki [1]
;
Thomas,Persse [4]
;
Patricia,Galipeau [4]
;
Scott,Wilkinson [6]
;
Shana Y,Trostel [6]
;
Fatima,Karzai [6]
;
Cindy H,Chau [6]
;
Erica L,Beatson [6]
;
Xiaohu,Zhang [7]
;
Carleen,Klumpp-Thomas [7]
;
Andreas,Varkaris [8]
;
Raul M,Luque [9]
;
Amanda,Swain [1]
;
Florence,Raynaud [1]
;
Nathan A,Lack [10]
;
Craig J,Thomas [11]
;
Gavin,Ha [4]
;
William D,Figg [6]
;
Marco,Bezzi [1]
;
Adam G,Sowalsky [6]
;
Peter S,Nelson [4]
;
Suzanne,Carreira [1]
;
Steven P,Balk [8]
;
Johann S,de Bono [12]
;
Adam,Sharp [13]
作者单位:
The Institute of Cancer Research, London, UK.
[1]
The Institute of Cancer Research, London, UK.;The Royal Marsden Hospital, London, UK.
[2]
The Institute of Cancer Research, London, UK.;Maimonides Institute for Biomedical Research of Cordoba (IMIBIC); Department of Cell Biology, Physiology, and Immunology, University of Cordoba; Reina Sofia University Hospital; CIBER Physiopathology of Obesity and Nutrition (CIBERobn), Cordoba, Spain.
[3]
Divisions of Human Biology and Clinical Research, Fred Hutchinson Cancer Center, Seattle, WA, USA.
[4]
Vancouver Prostate Centre, University of British Columbia, Vancouver, BC, Canada.
[5]
Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
[6]
Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institute of Health, Rockville, MD, USA.
[7]
Hematology-Oncology Division, Beth Israel Deaconess Medical Center, Boston, MA, USA.
[8]
Maimonides Institute for Biomedical Research of Cordoba (IMIBIC); Department of Cell Biology, Physiology, and Immunology, University of Cordoba; Reina Sofia University Hospital; CIBER Physiopathology of Obesity and Nutrition (CIBERobn), Cordoba, Spain.
[9]
Vancouver Prostate Centre, University of British Columbia, Vancouver, BC, Canada.;Department of Medical Pharmacology, School of Medicine, Koc University, Istanbul, Turkey.
[10]
Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institute of Health, Rockville, MD, USA.;Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
[11]
The Institute of Cancer Research, London, UK. johann.de-bono@icr.ac.uk.;The Royal Marsden Hospital, London, UK. johann.de-bono@icr.ac.uk.
[12]
The Institute of Cancer Research, London, UK. adam.sharp@icr.ac.uk.;The Royal Marsden Hospital, London, UK. adam.sharp@icr.ac.uk.
[13]
DOI
10.1038/s41467-025-64042-5
PMID
41062500
发布时间
2025-10-09